Cargando…
Multiobjective de novo drug design with recurrent neural networks and nondominated sorting
Research productivity in the pharmaceutical industry has declined significantly in recent decades, with higher costs, longer timelines, and lower success rates of drug candidates in clinical trials. This has prioritized the scalability and multiobjectivity of drug discovery and design. De novo drug...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026957/ https://www.ncbi.nlm.nih.gov/pubmed/33430996 http://dx.doi.org/10.1186/s13321-020-00419-6 |